Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898167 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Self-Testing to Increase Screening
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,474
- Enrollment target
NCT03898167 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 2,474 participants.
The verdict
NCT03898167, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,474 participants
- Enrollment target
Study Summary
Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.
Interventions
- BEHAVIORAL Patient Navigation
- BEHAVIORAL Telephone Recall
- BEHAVIORAL Mailed HPV Self-Sampling Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,474 participants |
| Start Date | 2020-02-13 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03898167
The ClinicalTrials.gov registry entry for NCT03898167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,474 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Patient Navigation is the first listed.
NCT03898167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03898167 about?
NCT03898167 is a clinical study titled "Prospective Evaluation of Self-Testing to Increase Screening". Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved...
What is the current status of trial NCT03898167?
This trial is currently completed. It is a NA study. The enrollment target is 2,474 participants. The study started on 2020-02-13. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03898167?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), Telephone Recall (BEHAVIORAL), Mailed HPV Self-Sampling Kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03898167?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.